MD Anderson, which has attracted a who's who in immuno-oncology as partners for its Moon Shots R&D program, is adding 6 new cancers to its list of targets. The research institution is doubling down on its moon shots, adding B-cell lymphomas, glioblastoma, HPV, multiple myeloma, colorectal and pancreatic cancers to the list. "As the Moon Shots Program matures, we're transitioning from the foundational phase to the results phase, and some moon shots already are making practice-changing advances in the clinic and in cancer prevention and control," says MD Anderson's Ronald DePinho. Release